Many thousands of people gathered on the National Mall today for the 47th annual March for Life, joined—for the first time—by a sitting president. President Trump praised the “strong women, amazing faith leaders,” and tens of thousands of young people he called “the heart of the March for Life. It is your generation that is making America a pro-family, pro-life … [Read more...] about Affirming and Celebrating Life
Published in Forbes
Grace-Marie frequently contributes articles to Forbes.com as an expert in Healthcare Policy.
A few months after Obamacare was enacted, three of my colleagues and I began work on a book to explain, as the title says, “Why Obamacare Is Wrong For America.” Why ObamaCare is Wrong for America It was published exactly a year after the law was signed, and virtually everything we predicted then has happened (except where parts of the law were subsequently changed, such as … [Read more...] about Obamacare’s Biggest Hits
Between Congress and the Courts, Obamacare took more hits this week: The most despised part of the ACA—the moribund individual mandate—was declared unconstitutional in a 2-1 decision by the Fifth Circuit Court of Appeals, but the judges left it to a lower court to sort out the complex task of deciding how much, if any, of the rest of the law should stand.Congress repealed for good three key … [Read more...] about More Hits And Misses For Obamacare
It won’t make the headlines, but Congress was hard at work this week producing health reform legislation around ideas that have bi-partisan support and which actually could become law. But that apparently is not Speaker Pelosi’s goal. Pelosi strong-armed her drug pricing bill, H.R. 3, through the House yesterday, with unanimous Democratic support and two Republican defections (Reps. … [Read more...] about Politics Prevail Over Solutions To Drug Pricing
Amidst the deluge of impeachment coverage, Speaker Pelosi has announced she will be bringing her aggressive prescription drug pricing bill to a vote in the House on Wednesday. The bill would impose destructive price controls on medicines, levy crushing taxes of 95% on sales if companies that don’t play along, and extend the price controls to private plans. The Council … [Read more...] about Hot topics: Drug prices and surprise bills